EUVIMEDEUVIMED entdecken
Open Access

Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib

Saihua Zhang, Hechun Lin, Junming Yu, Yunyu Wu, Changbing Wang, Lin Mao, Yizi Jin, Qin Geng, Shuqing Jiang, Xin Shen, Chao Ge, Taoyang Chen und 4 weitere

International Journal of Biological Sciences · 2026

DOI: 10.7150/ijbs.127395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Saihua Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 25…. Hauptthemen laut MEDLINE: Nebivolol, Carcinoma, Hepatocellular, Phenylurea Compounds, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NebivololCarcinoma, HepatocellularPhenylurea CompoundsLiver NeoplasmsQuinolinesHumansAnimalsMiceCell Line, TumorCell ProliferationAntineoplastic AgentsMice, Nude

Stichwörter der Autor:innen

Drug synergismHepatocellular carcinomaNebivololRHOQβ1-adrenergic receptor

Substanzen

NebivololPhenylurea CompoundsQuinolineslenvatinibAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 25/Ln 2200 Xietu Road, Shanghai 200032, China.
  • Department of Radiation Oncology, Shengli Oilfield Central Hospital, Dongying, Shandong 257000, China.
  • Department of Pathology, Qi Dong Liver Cancer Institute, Qidong 226220, China.
  • Department of Oncology, Huashan Hospital Fudan University, 12 Middle Urumqi Road, Shanghai 200000, China.

Zitieren

APA

Zhang, S., Lin, H., Yu, J., Wu, Y., Wang, C., Mao, L., Jin, Y., Geng, Q., Jiang, S., Shen, X., Ge, C., Chen, T., Li, J., Li, J., Xiao, X., & Li, H. (2026). Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.127395

Vancouver

Zhang S, Lin H, Yu J, Wu Y, Wang C, Mao L, et al. Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.127395

BibTeX
@article{Zhang2026,
  author = {Zhang, Saihua and Lin, Hechun and Yu, Junming and Wu, Yunyu and Wang, Changbing and Mao, Lin and Jin, Yizi and Geng, Qin and Jiang, Shuqing and Shen, Xin and Ge, Chao and Chen, Taoyang and Li, Jinjun and Li, Jing and Xiao, Xiuying and Li, Hong},
  title = {Nebivolol Inhibits Hepatocellular Carcinoma via RHOQ and Enhances the Efficacy of Lenvatinib},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  doi = {10.7150/ijbs.127395}
}
Kostenlos starten →